MTo assist government and private sector leaders better understand the unique threats and challenges of bioterrorism and the actions required for effective response should deterrence and prevention fail
GTo improve capability to respond to bioterrorism to a degree that, in effect, removes bioterrorism from the category of weapons of mass destruction
Juliet P. Brand
She is an epidemiologist and public health practitioner. She had held senior positions in local and state governmental public health where she enhanced system-wide capacity to detect, respond to, and contain large-scale disease outbreaks. She has served as a vice president for a 10-acute care hospital system initiating community-wide disease prevention programs. She has held faculty positions at Johns Hopkins University, and has developed graduate courses and lectured at numerous academic institutions on biosecurity. Dr. Gursky is currently a Fellow and Principal Deputy for Biodefense at ANSER/Analytic Services, Inc. where she heads the Health Security Strategy and Systems portfolio. In the past decade, Dr. Gursky has given over 50 invited talks nationally and internationally and has helped lead two, multi-country NATO-sponsored meetings relating to health security issues with health ministers and senior health leaders. She served on the AAAS Global Security Fellowship Selection Committee from 2005-2007 and in 2011. Dr. Gursky recently served on the Institute of Medicine Committee on the Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System. She has published over 35 peer-reviewed articles and nine book chapters. Dr. Gursky received her Doctor of Science degree in 1985 at the Johns Hopkins Bloomberg School of Public Health. She is a Fulbright Senior Specialist by the U.S. Department of State, Council for the International Exchange of Scholars.
Once the project’s Board of Advisors has determined metrics, a separate, independent team of subject matter experts will perform evaluation and analysis of capabilities in each category and subcategory. This team will include experienced practitioners and other thought leaders from academia, leading think tanks, and private sector organizations that specialize in biodefense, to ensure rigorous review and diverse perspectives. These experts will provide their analyses and insights to the WMD Center Board of Directors, who will make the final determination of grades, recommendations, and report content.
Release of the Report Card.
The Report Card will be published in October 2011, marking ten years after the 2001 anthrax attacks. The report will coincide with the release of Contagion, a dramatic, yet realistic Hollywood depiction of a 21st century public health crisis. The ability of a major feature film to help Americans imagine the realities of a bio-threat will complement the objective fact-finding, and assessment of the Bio-Response Capabilities Report Card.
State Of Biodefence.
The WMD Center and George Washington University’s Homeland Security Policy Institute hosted a special event on June 14, 2011, “The Threat of Bioterrorism: Improving America’s Response Capabilities.” This event featured former Senators Bob Graham (D-FL) and Jim Talent (R-MO), Chair and Vice Chair of the WMD Center, along with Senator Joe Lieberman (I-CT), Chairman of the Senate Homeland Security and Government Affairs Committee, and Representative Mike Rogers (R-MI), Chairman of the House Permanent Select Committee on Intelligence.
Senators Graham and Talent gave their first public presentation on the WMD Center’s upcoming Bio-Response Report Card. Due for release in mid-October, the Report Card brings together two dozen of the nation’s top experts in biodefense to analyze America’s progress in bio-response capabilities. The Report Card will fill the gap as the first strategic end-to-end assessment of the entire bio-response enterprise.
The distinguished panelists also discussed the WMD bills before the Senate and the House of Representatives, the role such legislation might play in improving America’s resilience to an act of bioterrorism, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.